Charter Research - Winter Park

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease4 trials

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Active, not recruiting2 trials
• Completed1 trial
• Enrolling by invitation1 trial

Lead sponsor

• Cognito Therapeutics, Inc.2 trials
• Acumen Pharmaceuticals1 trial
• Eli Lilly and Company1 trial

Running trials

• Enrolling by invitation

  Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)

  NCT06245031· Cognito Therapeutics, Inc.· Source

• Active, not recruiting

  A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD)

  NCT06335173· Phase 2· Acumen Pharmaceuticals· Source

• Active, not recruiting

  A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

  NCT04437511· Phase 3· Eli Lilly and Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease1 recruiting

Closed trials

• Completed

  A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)

  NCT05637801· Cognito Therapeutics, Inc.· Source